Dermapharm Holding SE's latest marketcap:
As of 06/26/2025, Dermapharm Holding SE's market capitalization has reached $2.18 B. According to our data, Dermapharm Holding SE is the 5760th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 2.18 B |
| Revenue (ttm) | 1.38 B |
| Net Income (ttm) | 119.04 M |
| Shares Out | 0 |
| EPS (ttm) | 2.21 |
| Forward PE | 14.46 |
| Ex-Dividend Date | 06/28/2024 |
| Earnings Date | 08/26/2025 |
Dermapharm Holding SE's yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 06/26/2025 | £2.18 B | -10.54% | 5760 |
| 12/30/2024 | £1.74 B | -12.22% | 5384 |
| 12/29/2023 | £1.98 B | 10.4% | 4854 |
| 12/30/2022 | £1.79 B | -55.58% | 5096 |
| 12/30/2021 | £4.03 B | 45.52% | 3011 |
| 12/30/2020 | £2.77 B | 51.67% | 3511 |
| 12/30/2019 | £1.83 B | 65.77% | 4036 |
| 12/28/2018 | £1.1 B | 5004 |
Company Profile
Company Overview
Dermapharm Holding SE, along with its subsidiaries, specializes in the manufacturing and sale of off-patent branded pharmaceutical products primarily in Germany.
Business Segments
- Branded Pharmaceuticals
- Other Healthcare Products
- Parallel Import Business
Product Portfolio
The company offers a diverse range of products, including:
- Branded generics and OTC products
- Non-prescription healthcare products and herbal extracts
- Parallel-imported originator pharmaceuticals
- Vitamins, minerals, and food supplements
- Dermatology, allergology, and pain/inflammation treatments
- Cardiovascular, gynecology, and urology products
- Cosmetics and medical devices
Key Brands
Dermapharm markets its products under well-known brands such as:
- Dekristol
- Keltican
- Tromcardin
- Ketozolin
- bite away
- Herpotherm
Corporate Details
Founded in 1991 and headquartered in Grünwald, Germany, Dermapharm Holding SE operates as a subsidiary of Themis Beteiligungs-AG.
Frequently Asked Questions
-
What is Dermapharm Holding SE's (LON-0A5J) current market cap?As of 06/26/2025, Dermapharm Holding SE (including the parent company, if applicable) has an estimated market capitalization of $2.18 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Dermapharm Holding SE (LON-0A5J) rank globally by market cap?Dermapharm Holding SE global market capitalization ranking is approximately 5760 as of 06/26/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.